Manulife (Manufacturers Life Insurance)’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-722
Closed -$26K 4487
2016
Q4
$26K Buy
722
+75
+12% +$2.65K ﹤0.01% 3562
2016
Q3
$25K Hold
647
﹤0.01% 3536
2016
Q2
$5K Sell
647
-145
-18% -$974 ﹤0.01% 3838
2016
Q1
$5K Buy
792
+647
+446% +$4.04K ﹤0.01% 3820
2015
Q4
$1 Hold
145
﹤0.01% 3965
2015
Q3
$1 Hold
145
﹤0.01% 4005
2015
Q2
$1 Buy
+145
New +$1.24K ﹤0.01% 3976

Other funds holding CLCD

Manulife (Manufacturers Life Insurance)'s CLCD Position: Q1 2017 in Review

Manulife (Manufacturers Life Insurance) sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 722 shares — an estimated $26K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CLCD in Q2 2015 and held it in 7 quarters. The position peaked at $26K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Manulife (Manufacturers Life Insurance) reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 722 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $26K.
  • Manulife (Manufacturers Life Insurance) first reported a position in CoLucid Pharmaceuticals, Inc. in Q2 2015 and held it in 7 quarters.
  • Manulife (Manufacturers Life Insurance)'s CoLucid Pharmaceuticals, Inc. position peaked at $26K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2017, filed 15 May 2017.